GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (XTAE:BWAY) » Definitions » Shiller PE Ratio

BrainsWay (XTAE:BWAY) Shiller PE Ratio : (As of May. 09, 2025)


View and export this data going back to 2007. Start your Free Trial

What is BrainsWay Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BrainsWay Shiller PE Ratio Historical Data

The historical data trend for BrainsWay's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay Shiller PE Ratio Chart

BrainsWay Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BrainsWay Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BrainsWay's Shiller PE Ratio

For the Medical Devices subindustry, BrainsWay's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrainsWay's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BrainsWay's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BrainsWay's Shiller PE Ratio falls into.


;
;

BrainsWay Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BrainsWay's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, BrainsWay's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.142/133.1571*133.1571
=0.142

Current CPI (Dec. 2024) = 133.1571.

BrainsWay Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.354 99.621 -0.473
201506 -0.177 100.684 -0.234
201509 -0.071 100.392 -0.094
201512 -0.390 99.792 -0.520
201603 -0.248 100.470 -0.329
201606 0.213 101.688 0.279
201609 -0.142 101.861 -0.186
201612 -0.390 101.863 -0.510
201703 -0.460 102.862 -0.595
201706 -0.106 103.349 -0.137
201709 -0.425 104.136 -0.543
201712 -0.673 104.011 -0.862
201803 -0.213 105.290 -0.269
201806 -0.425 106.317 -0.532
201809 -0.319 106.507 -0.399
201812 -0.496 105.998 -0.623
201903 -0.390 107.251 -0.484
201906 -0.602 108.070 -0.742
201909 -0.425 108.329 -0.522
201912 -0.354 108.420 -0.435
202003 -0.531 108.902 -0.649
202006 -0.106 108.767 -0.130
202009 -0.142 109.815 -0.172
202012 -0.071 109.897 -0.086
202103 -0.177 111.754 -0.211
202106 -0.213 114.631 -0.247
202109 -0.177 115.734 -0.204
202112 -0.142 117.630 -0.161
202203 -0.177 121.301 -0.194
202206 -0.248 125.017 -0.264
202209 -0.531 125.227 -0.565
202212 -0.425 125.222 -0.452
202303 -0.248 127.348 -0.259
202306 -0.177 128.729 -0.183
202309 -0.035 129.860 -0.036
202312 0.014 129.419 0.014
202403 0.012 131.776 0.012
202406 0.071 132.554 0.071
202409 0.071 133.029 0.071
202412 0.142 133.157 0.142

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BrainsWay  (XTAE:BWAY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BrainsWay Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of BrainsWay's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BrainsWay Business Description

Traded in Other Exchanges
Address
19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.